Understand how cardiometabolic care and obesity management play a crucial role in health management and complication prevention.

Abstract: A Comprehensive Guide to Integrative Metabolic Health and Weight Management

In this educational post, I, Dr. Alex Jimenez, DC, APRN, FNP-BC, CFMP, IFMCP, ATN, CCST, will guide you through a comprehensive, first-person narrative on the integrative diagnosis and management of obesity and its related metabolic conditions. We will explore complex patient cases—including a young woman with polycystic ovary syndrome (PCOS), insulin resistance, and binge eating disorder; a man navigating fertility issues, sarcopenic obesity, and severe cardiometabolic risk; and a perimenopausal woman facing hormonal shifts, weight gain, and functional decline. This post synthesizes the latest research from leading experts in obesity medicine, endocrinology, and metabolic physiology into a practical, evidence-based framework you can understand and apply.

I will walk you through the stepwise plans we develop at Injury Medical Clinic PA (Mission Plaza Injury Medical Clinic) in El Paso, Texas, where I work in close collaboration with our Medical Director and Collaborative Physician, Dr. Maria Guadalupe Cardenas, MD. Dr. Cardenas is Board Certified in Internal Medicine, holds NPI #1164426749 and Texas MD License #J2933, and brings over 40 years of invaluable internal medicine experience to our multidisciplinary team. Together, we blend medical oversight with functional medicine and integrative chiropractic care.

You will learn why and how we use:

• Advanced Diagnostics: We go beyond the scale, using metrics like fasting insulin, HOMA-IR, A1C, and body composition analysis to understand the root drivers of metabolic dysfunction.
• Modern Pharmacotherapies: We discuss the strategic use of medications like metformin, dual GLP-1/GIP receptor agonists (e.g., tirzepatide, semaglutide), bupropion/naltrexone, and others, all under careful medical supervision.
• Targeted Nutrition: We shift the focus from restrictive calorie counting to sustainable eating patterns, emphasizing protein, fiber, and nutrient timing to stabilize appetite and protect lean muscle mass.
• Integrative Chiropractic Care: I will explain how we address musculoskeletal pain, improve mobility, and support the autonomic nervous system to enhance exercise adherence, reduce stress, and improve overall function.
• Behavioral and Lifestyle Strategies: We cover the critical role of sleep, stress management, and psychological support in treating conditions like binge eating disorder and preventing weight cycling.

This guide is designed to be deeply informative and actionable, filled with clinical observations from our practice. My goal is to demystify complex conditions and show you exactly how an integrative team can help individuals move from metabolic chaos to stability, resilience, and lasting health.

Foundations of Our Integrative Care Model in El Paso, Texas

Hello, I’m Dr. Alex Jimenez. Welcome to our educational post, where we will journey through the complexities of modern, evidence-based obesity and metabolic health management. Over decades in clinical practice, I have cared for countless individuals struggling with obesity and its many interconnected drivers: insulin resistance, PCOS, dyslipidemia, fatty liver patterns, binge eating disorder, chronic stress, sleep disruption, and musculoskeletal pain that limits movement.

I practice in a collaborative model at Injury Medical Clinic PA (also known as Mission Plaza Injury Medical Clinic) in El Paso, Texas. This multidisciplinary setup, common in integrative and injury care, is designed to provide comprehensive, whole-person care. Our team is structured to leverage the strengths of different disciplines:

• Internal Medicine Oversight: Our practice is anchored by the deep expertise of our Medical Director and Collaborative Physician, Maria Guadalupe Cardenas, MD. Dr. Cardenas is Board Certified in Internal Medicine, with an NPI #1164426749 and Texas MD License #J2933. With over 40 years of distinguished experience as an internist, she provides essential medical oversight, prescribes and manages medications, orders and interprets diagnostic tests, coordinates referrals, and works side-by-side with me to ensure every treatment plan is safe, effective, and aligned with the latest evidence-based guidelines.
• Integrative Chiropractic and Functional Medicine: My role, as Dr. Alex Jimenez, DC, APRN, FNP-BC, CFMP, IFMCP, ATN, CCST, is to bridge the gap between structure and function. I provide integrative chiropractic care focusing on neuro-musculoskeletal optimization, autonomic regulation, and movement efficiency. As an advanced practice registered nurse, board-certified family nurse practitioner, and functional medicine practitioner, I also guide our functional medicine strategies, rehabilitation, nutritional counseling, and data-driven tracking of cardiometabolic markers.
• Multidisciplinary Coordination: Our team also includes registered dietitians, physical therapists, exercise specialists, and behavioral health professionals. This allows us to offer a truly holistic treatment environment, ensuring that every aspect of a person’s health is addressed—from their diet and exercise to their mental and emotional well-being.

This MD-DC collaboration is the hallmark of our clinic. It ensures that when we manage complex conditions like obesity, we do so with a comprehensive approach that respects the intricate interplay between a person’s metabolism, movement, mood, and mindset.

Understanding Obesity Through a Systems Lens: Why Integrative Care Matters

I have long believed—and confirmed through clinical practice—that obesity is not a willpower problem. It is a complex, multifactorial condition, driven by a mix of genetic vulnerabilities, endocrine imbalances, neurobiological signaling, environmental exposures, dietary patterns, sleep and stress states, musculoskeletal constraints, and social determinants of health. When I meet a patient with obesity, I look for drivers across multiple systems:

• Endocrine and Metabolic Drivers

• Insulin resistance and hyperinsulinemia: These are often the central culprits behind fat accumulation, appetite dysregulation, and energy swings.
• PCOS: A common condition in women characterized by hyperandrogenism, ovulatory dysfunction, and a distinctive metabolic profile.
• Thyroid function: Even subclinical hypothyroidism can alter weight regulation and mood.
• Adrenal stress patterns: Chronic stress influences glucose, insulin, and appetite in a vicious cycle.

• Gastrointestinal and Microbiome Drivers

• Dysbiosis and gut permeability (“leaky gut” ): These are associated with systemic inflammation, insulin resistance, and cravings.
• Dietary inflammatory load: Ultra-processed foods can modulate the brain’s reward circuitry and negatively impact the gut microbiome.
• Bile acid signaling and incretin hormones: Pathways involving hormones like GLP-1 and GIP are crucial for satiety and insulin dynamics.

• Neurobehavioral and Psychosocial Drivers

• Binge eating disorder: This often involves cycles of shame, distress, and large food intake, frequently co-occurring with restrictive eating patterns.
• Sleep disruption: Even mild sleep loss can amplify the hunger hormone ghrelin, reduce leptin signaling, and increase cravings for highly palatable foods.
• Stress and trauma: A history of stress or trauma can tilt the autonomic nervous system toward a “fight or flight” state, influencing cortisol levels and reward-seeking behaviors.

• Musculoskeletal and Movement Drivers

• Pain and biomechanical asymmetry: These issues can reduce physical activity and impede the body’s ability to become more insulin-sensitive.
• Fascial restrictions: These can alter proprioception (the body’s sense of its position in space) and affect energy expenditure patterns.
• Deconditioning: A decline in physical fitness can lead to greater weight cycling and metabolic inflexibility.

Integrative chiropractic care fits into this matrix by addressing the structural and neuromuscular factors that impact movement, autonomic balance, and pain. When movement is efficient and comfortable, patients can engage in regular exercise that becomes a powerful metabolic therapy, not a chore. Chiropractic techniques, when appropriately selected and medically overseen, can modulate sensory input to the brain, improve joint mechanics, reduce pain signals, and help shift the autonomic nervous system toward a more parasympathetic (“rest and digest”) state. All of these effects support better appetite regulation, sleep quality, and insulin sensitivity.

Working in close collaboration with Dr. Cardenas, we ensure that pharmacotherapies, diagnostics, and medical risk management are seamlessly integrated with structural care, rehabilitation, and functional medicine. This coordination is crucial when we introduce agents like metformin or GLP-1/GIP receptor agonists, screen for comorbidities, and time interventions around a patient’s life goals, such as fertility. Patients benefit from clear medical direction combined with a practical mechanotherapy plan that improves their daily function.

In what follows, I will narrate the journeys of several composite patients, expanding on the science and explaining the reasoning behind each intervention. My goal is to make this educational, translational, and clear—so you can see exactly how our integrative team helps people move from metabolic chaos to stability, resilience, and health.

Case Study 1: Eloise’s Journey with PCOS, Insulin Resistance, and Binge Eating Disorder

To illustrate our approach, let me introduce you to Eloise. She is a 25-year-old fitness director at her local YMCA, highly physically active, yet her history with weight management has been complicated. She represents a classic clinical pattern we frequently see in our practice.

Introducing the Patient: A Profile of Metabolic and Hormonal Dysregulation

Eloise came to her primary care provider for an annual examination with the following concerns:

• Lifelong weight challenges: She reported multiple attempts to lose weight, always followed by regain. Despite her high activity level, she had recently reached her highest weight ever.
• Restrictive eating patterns: She felt anxious if her daily calorie intake exceeded 1,200, a pattern that often led to episodic binge eating, which she had experienced since age 16.
• Reproductive history: Her menstrual cycles had been irregular and infrequent since adolescence. She and her husband had been sexually active for five years without using contraception and had never conceived. She expressed a desire for a future pregnancy.
• Eating and activity patterns: She typically ate two large meals a day (lunch and dinner) and experienced intense evening cravings. For the past two years, she had binge episodes 1-2 times per week, often triggered by a perceived dietary failure. Her activity level was high: 45 minutes on the elliptical 4 days/week, 45 minutes of strength training 2 days/week, and yoga twice a week.

Her vital signs and lab work painted a very clear picture of what was happening under the surface:

• BMI: 37.5 (Class II Obesity)
• Fasting Insulin: 36.1 ?U/mL (Marked hyperinsulinemia)
• Fasting Glucose: 107 mg/dL (Impaired fasting glucose)
• HOMA-IR: 9.5 (Significant insulin resistance)
• A1C: 6.0% (Prediabetes range)
• Dyslipidemia: Elevated triglycerides, low HDL (“good” cholesterol), and elevated LDL (“bad” cholesterol).
• Liver Enzymes: Elevated, suggesting stress on the liver.
• Physical Exam Findings: We noted an increased waist circumference (central adiposity), acanthosis nigricans (dark, velvety skin patches) around her neck, and skin tags on her neck and underarms—all classic external signs of high insulin levels. She also had cystic acne on her face and chest and mild hirsutism (excess hair growth) on her upper lip.

Based on this comprehensive evaluation, our diagnostic impressions were:

• Class II obesity
• Polycystic ovary syndrome (PCOS), meeting 2 of the 3 Rotterdam criteria (hyperandrogenism and ovulatory dysfunction).
• Infertility by history.
• Insulin resistance, prediabetes, and hyperinsulinemia.
• Atherogenic dyslipidemia.
• Elevated liver enzymes, likely indicating early-stage fatty liver disease.
• Binge eating disorder with a cycle of restriction and weight cycling.

I am often asked how we screen for binge eating disorder. In my practice, this is a routine part of our intake process. We use validated tools like the BEDS-7 (Binge Eating Disorder Screener-7) to assess the frequency of eating unusually large amounts of food, a perceived loss of control, and the level of distress associated with these episodes. A score above 5 on this screener is highly suggestive of the disorder (Hudson et al., 2014). Eloise’s personal narrative, with its themes of restriction-triggered binges, marked distress, and shame, was consistent with a clinical diagnosis.

Why This Presentation Matters: Cardiometabolic and Reproductive Risk

PCOS is a chronic condition, and its associated cardiometabolic risks persist across a woman’s lifespan, even after menopause. Insulin resistance is the underlying driver of many PCOS manifestations—including hyperandrogenism, anovulation, central adiposity, and dyslipidemia—and it significantly compounds the risk for type 2 diabetes, metabolic-associated steatotic liver disease (MASLD), hypertension, and atherosclerotic cardiovascular disease (Wild et al., 2010).

The cycle of binge eating and restriction further amplifies this risk. It creates physiological stress, disrupts sleep, and promotes weight cycling, which can erode lean muscle mass over time. As lean mass decreases and fat mass increases, metabolic flexibility worsens, making it even harder to manage weight and blood sugar.

Our priorities for Eloise were clear:

• Stabilize her blood sugar and insulin dynamics.
• Reduce her excess androgen levels by lowering insulin.
• Protect and increase her lean mass while reducing harmful visceral fat.
• Restore her ovulatory cycles to improve fertility prospects.
• Treat her binge eating disorder to reduce psychological distress and physiological swings.
• Prevent further weight cycling and the associated loss of muscle.
• Improve her lipid profile and liver enzymes.
• Set realistic, staged goals and track biomarkers to build and maintain momentum.

Building a Stepwise Plan: Goals and Initial Strategy

We began by setting clear, measurable goals with Eloise:

• Initial weight reduction target: Approximately 10% of her body weight.
• Cardiometabolic risk reduction: Lower her insulin, improve her HOMA-IR, reduce her A1C, and normalize her triglycerides and HDL.
• Improve PCOS manifestations: Reduce her acne and hirsutism and promote cycle regularity.
• Restore ovulation and fertility readiness: We would also implement contraception to allow her to time a future pregnancy safely, once her metabolic health was optimized.
• Reduce binge eating: Decrease the frequency and distress of binge episodes and address the restrictive triggers.
• Enhance quality of life: Improve her sleep, energy levels, and emotional well-being.

Our first-phase interventions were introduced in a staged sequence to avoid overwhelming her, especially given that aggressive dietary restriction could worsen her binging.

Nutrition Patterning for Insulin Resistance and PCOS

We immediately worked to shift her mindset from anxious calorie counting to building a sustainable eating pattern.

• Shift from Calorie Counting to Eating Patterns:

• Eat every 3–4 hours: We recommended 4–5 smaller meals or structured snacks throughout the day.
• Daily protein target: 90–100 grams, distributed across her meals to stabilize satiety and support lean mass.
• Emphasize fiber: Aim for 50–100 grams of total fiber-containing produce (vegetables and low-sugar fruits) per day.
• Minimize problematic foods: We advised her to reduce ultra-processed foods, sugary snacks, refined grains, and alcohol, particularly in the evening.

• Rationale:

• Frequent, protein-anchored meals help attenuate glycemic excursions and reduce the compensatory hyperinsulinemia that was driving her fat storage and hunger (Ludwig & Ebbeling, 2018).
• Fiber modulates the gut microbiota, bile acid signaling, and the release of incretin hormones like GLP-1, all of which improve insulin sensitivity and satiety.
• Minimizing ultra-processed foods helps reduce dopamine-driven reward eating and inflammatory exposures (Hall et al., 2019).
• This rhythmic eating pattern helps break the psychological pressure of a 1,200-calorie ceiling and interrupts the restrict-binge cycle.

Exercise and Movement

Eloise was already very active, so our goal was not to add more intense exercise, but to make her existing routine more metabolically effective.

• Maintain Current Regimen: She continued her elliptical, strength training, and yoga routine.
• Add Brief Daily Aerobic Bouts:

• We asked her to add a 10-minute walk after meals or during the day, aiming for at least one session initially.

• Rationale:

• Short, frequent bouts of moderate activity are highly insulin-sensitizing. They help muscle cells take up glucose from the blood via GLUT4 translocation, which lowers post-meal glucose spikes (Jensen et al., 2014).
• Her strength training was crucial for preserving and building lean mass, which improves basal metabolic rate and insulin sensitivity.
• Her yoga practice supports autonomic balance, helping to reduce the sympathetic overdrive and cortisol-driven cravings that can fuel binge eating.

Pharmacotherapy and Medical Oversight

Under the direct supervision of Dr. Cardenas, we initiated a multi-pronged pharmacotherapy plan.

• Initiate Metformin ER: We started her on metformin extended-release (ER) 500 mg daily, with a plan to titrate up to 2,000 mg/day as tolerated.

• Rationale: Metformin is widely used off-label for PCOS and prediabetes. It works primarily by reducing the liver’s production of glucose (hepatic gluconeogenesis) and improving peripheral insulin sensitivity. It can also modestly reduce androgens and support the restoration of ovulation when combined with weight loss (Jian et al., 2013). The ER formulation helps reduce the gastrointestinal side effects that are common with the immediate-release version.

• Initiate a Combined Oral Contraceptive:

• Rationale: This helps improve menstrual regularity, reduce acne and hirsutism, and protect the endometrium from the risks associated with infrequent cycles. Crucially, it also protects against unintended pregnancy while her metabolic health is being optimized.

• Consider Tirzepatide: Once she was stable on metformin, we planned to introduce tirzepatide, a dual GLP-1/GIP receptor agonist.

• Rationale: This class of medication is a game-changer for many patients. It potently regulates appetite, improves insulin sensitivity, promotes significant weight loss, and reduces cardiometabolic risk. By stabilizing satiety and attenuating reward-driven eating, it frequently reduces the frequency and severity of binge episodes (Jastreboff et al., 2022).
• We counseled her on the need for barrier contraception during the first 4 weeks of starting tirzepatide and for 4 weeks after each dose increase. This is because the medication slows gastric emptying, which can potentially impair the absorption of oral contraceptive pills.

• Contingency Plan for Binge Eating: If her binge eating persisted despite the GLP-1/GIP agonist, we discussed the option of considering lisdexamfetamine, which is FDA-approved for the treatment of binge eating disorder.

• Rationale: This medication can reduce the frequency and urgency of binges by modulating catecholaminergic pathways in the brain related to impulse control and reward.

Integrative Chiropractic Care

My role was to address the structural and neuromuscular components of her health.

• Structural Evaluation:

• I assessed her spinal alignment, pelvic mechanics, and the mobility of her ribcage and diaphragm. I also screened for pain generators (such as lumbar facets or the SI joint) that might undermine her consistency in movement.

• Targeted Interventions:

• I used low-force spinal manipulation to optimize joint kinematics and reduce pain signals.
• I used myofascial release and instrument-assisted soft tissue mobilization to improve fascial glide and enhance proprioception.
• I coached her on breathing mechanics to improve diaphragmatic engagement. This, along with optimizing cervicothoracic alignment, can help support vagal tone.

• Rationale:

• Modulating the autonomic nervous system toward a more parasympathetic state can help reduce stress-driven eating and improve sleep.
• Reducing pain promotes adherence to her activity plan.
• Optimizing proprioception supports movement efficiency, which further enhances insulin sensitization.

Behavioral and Psychological Support

• BEDS-7 Monitoring and Cognitive-Behavioral Strategies: We continued to monitor her binge eating symptoms and introduced cognitive-behavioral strategies to help her reframe dietary lapses and reduce the cycle of shame.
• Structured Evening Routine: We helped her create a structured evening routine, her highest-risk period for cravings. This included a protein-forward snack before her typical binge window and non-food coping rituals like journaling, a brief yoga session, or a walk.
• Sleep Optimization: We emphasized consistent sleep and wake times, along with strategies to manage sleep disruption after any residual binge episodes.

• Rationale: Sleep restriction is known to affect the appetite hormones ghrelin and leptin and activate reward circuitry in the brain, fueling cravings for high-calorie foods (Buxton et al., 2012).

First Follow-Up: Six Months of Progress

At her six-month follow-up, Eloise was doing exceptionally well.

• She was tolerating her metformin and had titrated her tirzepatide up to 10 mg weekly, which she described as her “sweet spot.”
• She reported a significant reduction in acne and hirsutism.
• She had embraced the eating pattern approach and was no longer rigidly counting calories.
• Her binge episodes had dramatically reduced from 1-2 times per week to only 1-2 times per month, and they were now typically triggered by stress rather than dietary restriction.
• Her activity routine was sustained, and she had successfully added daily 10-minute walks.

Her biomarkers showed meaningful improvement:

• Weight loss: 11% of her initial body weight.
• Fasting insulin: Down to 21.4 ?U/mL. Still elevated, but markedly improved from 36.1.
• Her fasting glucose, HOMA-IR, and A1C were all trending downward.
• Her dyslipidemia was improving, and her liver enzymes were moving toward the normal range.
• She no longer met the full criteria for binge eating disorder.

Long-Term Trajectory: Two Years and Fertility Planning

At the two-year mark, Eloise’s transformation was sustained.

• She was maintaining her medications. Her binge eating was fully controlled after a brief course of lisdexamfetamine. Her cravings were minimal, her physical activity was consistent, and her sleep was stable.
• She and her husband were now considering a transition to a barrier method of contraception to assess the return of her natural cycles in preparation for pregnancy.

Her biomarkers were remarkable:

• Weight loss: 24.1% of her initial body weight.
• Fasting insulin: 8.4 ?U/mL (approaching the ideal range of 5-6).
• HOMA-IR: Within the normal range.
• A1C: 5.2%.
• Her lipids and liver enzymes had normalized.

Eloise’s journey demonstrates how a comprehensive, stepwise approach can lead to profound and lasting change. By improving her metabolic health, we not only reduced her long-term cardiometabolic risk but also significantly improved her fertility prospects, giving her a strong foundation to plan for a safe and healthy pregnancy with medical guidance.

Transform Your Body!- Video

Case Study 2: George and Lynn’s Journey Through Metabolic Health, Fertility, and Midlife Transitions

Now, let’s explore the stories of two other composite patients, George and Lynn. Their journeys highlight how we apply similar integrative principles to address a different set of challenges, including male infertility, stress-related eating, perimenopausal weight gain, and grief.

George’s Story: Reclaiming Metabolic Health and Fertility

George was a 35-year-old project manager who came to us with several concerns. He and his wife were trying for their second child, and he had been told he had a low sperm count. He was also dealing with elevated blood pressure, symptoms of depression and anxiety, and high levels of stress from his long commute and demanding job. His father had a history of heart failure, and George was worried about his own cardiovascular risk.

The Metabolic-Hormonal Loop That Trapped George

George felt a deep sense of shame about his frequent hunger and perceived lack of control over his appetite. My first conversation with him was focused on reframing this from a character flaw to a biological reality. I explained the concept of “chemical versus character.” In states of metabolic dysfunction, hunger and cravings are often the product of dysregulated hormonal and neurobiological signals, not a personal failure.

I walked him through the physiology in plain language:

• Adipose Tissue as an Endocrine Organ: Excess visceral adipose tissue (the fat around the organs) produces inflammatory signals that worsen insulin resistance. Furthermore, an enzyme in fat tissue called aromatase converts androgens (like testosterone) into estrogens. In men, this can lead to decreased circulating testosterone, which impairs sperm production, libido, and erectile function.
• Insulin and Appetite Signaling: His hyperinsulinemia was promoting fat storage. The resulting insulin resistance meant his cells weren’t getting the glucose they needed, which perpetuated a cycle of hunger.
• The Stress-Craving Spiral: His chronic stress was elevating cortisol, which drives appetite for high-glycemic foods and shifts fat storage to the abdominal area.

A Stepwise Plan for George

Under Dr. Cardenas’s medical supervision, we developed a comprehensive plan:

1. Complete Lab Work: We ordered an A1C, a comprehensive thyroid panel, and a liver panel to get a full picture of his metabolic health.
2. Blood Pressure Management: Dr. Cardenas initiated a first-line antihypertensive medication and coached him on home blood pressure monitoring.
3. Sleep Evaluation: We referred him for a sleep study to evaluate for obstructive sleep apnea (OSA), a common and often undiagnosed condition in men with his profile.
4. Nutrition Therapy: We referred him to a dietitian to help him build a structured meal pattern emphasizing protein and fiber and develop strategies for navigating the challenging food environment at his workplace.
5. Stress and Mood Support: We started with a simple, achievable goal: a 3-minute meditation in his car after his commute, before walking into work. This provided a private space for him to build a new habit.
6. Medication Discussion for Appetite: We educated him on pharmacotherapy options, including the bupropion/naltrexone combination, which can help with cravings and mood.

At his four-week follow-up, George had completed his labs, which confirmed he was in the prediabetes range. He had started his blood pressure medication but was still struggling with stress eating and soda consumption. We normalized this, reframing the setback as useful data. Dr. Cardenas adjusted his blood pressure medication, and we planned to start the bupropion/naltrexone after his sleep study was completed.

Four months into his care, the momentum was building. His sleep study confirmed OSA, and he had started using a CPAP machine. His mood had improved with the bupropion-based regimen. He was taking lunch-break walks. However, he was still struggling with significant hunger and asked about the injectable medications he had heard about.

After a thorough discussion and with insurance coverage confirmed, Dr. Cardenas initiated semaglutide, a GLP-1 receptor agonist. We also strongly encouraged him to start a progressive resistance training program 2-3 days per week to protect his muscle mass during weight loss.

One-Year Follow-Up: An Inspiring Turnaround

A year later, the results were inspiring.

• His wife was pregnant with their baby girl.
• His blood pressure was well-controlled.
• His metabolic markers had improved dramatically. His HOMA-IR had dropped from 3.1 to 1.64, and he was no longer in the prediabetes range.
• His waist circumference was significantly reduced, and he had lost a substantial amount of weight.
• The Role of Chiropractic Care: As George became more active, my role was to address the musculoskeletal strain from his desk job and long commute. Through chiropractic adjustments and soft-tissue techniques, we improved his thoracic and cervical mobility, which helped his breathing mechanics and reduced discomfort. This supportive care eased his stress, improved his recovery, and helped him stay consistent with his activity plan.

Lynn’s Story: Navigating Perimenopause, Grief, and Metabolic Shifts

Lynn was a 42-year-old event planner who presented with fatigue, brain fog, poor sleep, mood swings, hot flashes, and a 20-pound weight gain. She was also grieving the loss of her father six months prior. She felt her previous concerns about perimenopause had been dismissed, leaving her feeling unsupported.

Understanding Lynn’s Physiology

Lynn’s symptoms were a result of several interconnected factors:

• Perimenopausal Hormonal Variability: Fluctuating estradiol and progesterone levels were destabilizing her body’s ability to regulate temperature, sleep, and mood. This hormonal flux can also directly impair glucose metabolism and lipid profiles.
• Metabolic Liver Signals: Her mildly elevated liver enzymes, combined with an increased waist circumference, raised concern for metabolic-associated steatotic liver disease (MASLD).
• Grief and Stress: Prolonged grief can lead to sleep disturbances, emotional eating, and an increase in physiological stress, all of which contribute to weight gain and metabolic dysfunction.

An Integrative Plan for Lynn

Our approach for Lynn was patient-centered and stepwise. A thoughtful question arose: “Why did you start menopausal hormone therapy instead of an obesity medication?” The answer lies in shared decision-making. For Lynn, the most debilitating symptoms were fatigue, brain fog, and poor sleep. It was essential to address these foundational issues first.

1. Menopausal Hormone Therapy (MHT): Because she met the safety criteria, Dr. Cardenas initiated transdermal estrogen with progesterone. The transdermal route was chosen because it bypasses the liver, reducing the risk of blood clots, and provides more stable hormone levels.
2. Grief Counseling: We referred her for therapy to help her process her bereavement.
3. Tailored Physical Activity: We helped her find a pragmatic routine she could stick to—walking during her daughter’s ballet classes instead of scrolling on her phone.
4. Nutrition Therapy: A dietitian helped her implement a Mediterranean-style eating pattern, which is well-supported by evidence for improving liver health and cardiometabolic risk.
5. Integrative Chiropractic Care: My focus was on addressing the back and neck discomfort that was hindering her activity. By improving her thoracic and pelvic biomechanics, we reduced pain barriers and supported her autonomic balance, which is critical for sleep and stress regulation.

At her six-week follow-up, the transformation was remarkable. The MHT had significantly improved her sleep, brain fog, and fatigue. This gave her the energy and motivation to engage more fully with her nutrition and exercise plan. With these initial goals met, we then introduced Tirzepatide to address the persistent weight management challenges.

Three years later, Lynn is now 45 and has successfully maintained her health improvements. She continues her MHT and a maintenance dose of Tirzepatide. She found an exercise class she loves, continues to check in with her dietitian, and has proactively restarted therapy to cope with new life stressors. Her journey is a testament to how addressing hormonal balance and mental health can be the key to unlocking sustainable metabolic change.

Case Study 3: Amit and Dolores’s Journey Through Sarcopenic Obesity and Mobility Limitations

Now, I want to introduce you to two more patients, Amit and Dolores, whose cases highlight our approach to severe metabolic disease, sarcopenic obesity, and the challenges of aging with mobility limitations.

Amit’s Journey: Tackling Sarcopenic Obesity and High Cardiovascular Risk

Amit was a 57-year-old male with an extensive and complex health history that placed him at extremely high risk for future cardiovascular events. His diagnoses included:

• Type 2 Diabetes on a multi-injection insulin regimen.
• A prior Myocardial Infarction (MI).
• Peripheral Artery Disease (PAD) with intermittent claudication (leg pain with walking).
• Obstructive Sleep Apnea (OSA).
• Sarcopenic Obesity: This was the most critical diagnosis. His body composition analysis revealed a body fat percentage of 56.7% and a skeletal muscle mass in the 4th percentile for his age. This dangerous combination of high fat and critically low muscle carries a much higher risk of mortality and morbidity than either obesity or sarcopenia alone (Stenholm et al., 2008).

Amit reported feeling hungry almost all the time, a classic sign of severe hormonal dysregulation. Our primary goals were to improve his body composition (lose fat, gain muscle), reduce his cardiometabolic risk, and improve his physical function and quality of life.

A Multifaceted Treatment Plan for Amit

Our stepwise plan was aggressive yet carefully orchestrated.

1. Nutritional Intervention: We recommended a modified Mediterranean-style diet with a strong focus on protein. The target was 90-100 grams of protein per day, spaced out every 3-4 hours to maximize muscle protein synthesis (MPS) (Areta et al., 2013).
2. Supervised Physical Activity: Given his PAD, he was referred to physical therapy for a structured, supervised exercise program.
3. Pharmacotherapy: This was the most critical intervention.

• Initiating Semaglutide: We chose semaglutide and planned to titrate it up to the 2.4 mg dose. The choice was deliberate: in addition to its powerful weight loss effects, Semaglutide 2.4 mg has an FDA indication to reduce the risk of major adverse cardiovascular events (MACE) in adults with established cardiovascular disease and obesity (Ryan et al., 2024). Amit qualified for this indication in multiple ways.
• Deprescribing Insulin: This was a vital and often overlooked step. While his insulin regimen was keeping his A1c “controlled,” exogenous insulin is a powerful fat-storage hormone. It is profoundly obesogenic and pro-inflammatory. Our goal was to get him off insulin entirely. Under Dr. Cardenas’s guidance, we planned to taper his insulin as we titrated the semaglutide carefully. A continuous glucose monitor (CGM) was an invaluable tool in this process, providing real-time data to guide our decisions safely.

At his six-month follow-up, the progress was outstanding. He had successfully tapered off all of his insulin. His constant hunger and cravings were dramatically reduced. He had achieved a 10.2% body weight reduction, which was remarkable given his starting point. He had less claudication pain and more stamina. As his function improved, integrative chiropractic care became essential. By improving his spinal and pelvic biomechanics and addressing joint restrictions, we helped reduce compensatory pain and supported his physical therapy goals, allowing him to continue making progress.

Dolores’s Journey: Navigating Sarcopenic Obesity and Surgical Preparation

Dolores was a 72-year-old retired woman who was limited by severe knee osteoarthritis. She was hoping to get bilateral total knee replacements but was told she needed to have a BMI < 40 to qualify for surgery.

Her baseline metrics revealed sarcopenic obesity: a BMI of 41.5, a body fat percentage of 56.8%, and a skeletal muscle mass in the 2nd percentile. Our clinical priorities were to help her lose enough weight to qualify for surgery while preserving or increasing her precious muscle mass, and to manage the health inequities and weight bias she feared she would face.

An Integrative Plan for Dolores

1. Nutrition Plan: Dolores disliked meat and preferred small portions. We worked with a registered dietitian to create a plan rich in animal-protein alternatives like eggs, seafood, cottage cheese, and Greek yogurt, aiming for 90-100 grams of protein daily, spaced throughout the day.
2. Physical Therapy and Graded Activity: Her activity was limited to swimming. We referred her to PT for a program focused on aquatic therapy and stationary cycling to reduce joint load, as well as targeted strengthening exercises for the muscles around her knees.
3. Pharmacotherapy: After a shared decision-making discussion, we initiated naltrexone-bupropion to help with her evening sweet cravings. We also discussed GLP-1 agonists as a future option.
4. Addressing Bias and Patient Advocacy: Dolores feared being judged by her physical therapist and surgeon. This is a common and valid barrier. I validated her experiences and explicitly told her we would advocate for her. I coached her on scripts to use in her appointments to reframe the conversation around her progress and needs, positioning her as an active partner in her care.

One year later, Dolores had achieved an 8.7% weight reduction. Her muscle mass had increased to the 10th percentile. She had one knee successfully replaced and was preparing for the second. She had transitioned to semaglutide to support her continued progress. My integrative chiropractic care was crucial in this journey. By improving her lumbopelvic mechanics, enhancing ankle and hip mobility, and training her proprioception, we reduced her pain, improved her confidence with movement, and made it possible for her to consistently participate in her physical therapy and prepare successfully for surgery.

Key Clinical Concepts and Our Integrative Approach

The journeys of Eloise, George, Lynn, Amit, and Dolores illustrate several core principles that guide our practice.

Evidence-Based Metrics That Drive Care

We go beyond the scale to understand a patient’s metabolic health.

• Fasting Insulin and HOMA-IR: These are our most valuable tools for quantifying insulin resistance. An elevated fasting insulin is often the earliest sign of metabolic dysfunction, long before A1C rises.
• Body Composition: We use tools like DEXA or Bioelectrical Impedance Analysis (BIA) to measure percent body fat, skeletal muscle mass, and visceral adipose tissue (VAT). Changes in these compartments are stronger predictors of function and risk than scale weight alone (Neeland et al., 2019). Preserving muscle is a cornerstone of our approach.

Sarcopenia and Muscle-Centric Metabolism

Skeletal muscle is our body’s largest glucose sink and our primary metabolic engine. Losing muscle, a condition called sarcopenia, slows metabolism and worsens insulin resistance. This is why our plans always include two key components to combat muscle loss, especially during weight reduction:

• Adequate Protein Intake: We typically target 1.2–1.6 g/kg of ideal body weight per day, spaced throughout the day to maximize muscle protein synthesis (Bauer et al., 2013).
• Resistance Training: This is the most effective stimulus for building and maintaining muscle.

The Biology of Weight Loss: Why Hunger Returns

The body is biologically programmed to defend against fat loss. As weight declines, hunger signals (like ghrelin) increase and satiety signals (like leptin) decrease (Rosenbaum & Leibel, 2010). This is a normal physiological response, not a moral failing. We counter this by:

• Using GLP-1 receptor agonists to reinforce satiety signals.
• Increasing protein
• Implementing resistance training to preserve resting energy expenditure.
• Considering adjunct anti-obesity medications like phentermine or bupropion-naltrexone to manage persistent hunger, all under Dr. Cardenas’s careful medical oversight.

Integrative Chiropractic Care in Metabolic Health

My role as an integrative chiropractor is to ensure patients can move well and without pain, enabling them to follow through on their activity prescriptions. The mechanisms include:

• Pain Modulation: Manual therapies can reduce pain signals, allowing for more regular exercise (Coronado et al., 2012).
• Autonomic Balance: Chiropractic care can help shift the nervous system toward a more parasympathetic state, which supports recovery, sleep, and stress regulation (Haavik & Murphy, 2018).
• Proprioceptive Optimization: Improving the body’s sense of position and movement enhances efficiency and reduces injury risk.
• Kinetic Chain Integration: Addressing issues in the spine and pelvis can optimize loading patterns in the knees and ankles, which is crucial for patients with osteoarthritis.

Clinical Observations From Our Practice in El Paso

Across thousands of patient interactions at Injury Medical Clinic PA, our multidisciplinary model consistently shows:

• Patients adhere better to their plans when pain is reduced, and movement is enjoyable.
• Structured nutrition patterns are far more sustainable than rigid calorie limits.
• GLP-1/GIP therapies can transform a patient’s relationship with food by reducing binge frequency and “food noise.”
• Even modest amounts of daily walking (10-15 minutes) can meaningfully improve glycemic control and mood.
• Collaborating with an experienced internist like Dr. Cardenas enhances safety, precision, and patient confidence, especially when managing complex pharmacotherapy.
• A compassionate, realistic, and patient-aligned plan is the key to improving outcomes.

Readers can find more of my clinical reflections and patient-centered guidance on my professional platforms:

• Injury Medical Clinic PA: https://personalinjurydoctorgroup.com/
• Professional Profile: https://www.linkedin.com/in/dralexjimenez/

Conclusion: A Holistic Path to Metabolic Recovery and Quality of Life

I am continually inspired by the patients who commit to this journey. Through scientifically grounded interventions, compassionate behavioral support, and integrated structural care, individuals can reclaim their metabolic health and live with energy, clarity, and confidence. The cases of Eloise, George, Lynn, Amit, and Dolores demonstrate that high activity alone cannot overcome severe insulin resistance; that structured feeding can disrupt the restrict-binge cycle; and that protecting lean mass is non-negotiable.

Working alongside Dr. Maria Guadalupe Cardenas, MD, we deliver a model of care that is both rigorous and human—one that respects the science and the person. This collaborative model allows us to address the whole person—their metabolism, movement, mood, and mindset—providing a comprehensive and durable path to metabolic recovery, reproductive health, and an enhanced quality of life.

Actionable Checklist for Clinicians and Patients

• Set clear goals: Focus on weight, biomarkers (fasting insulin, HOMA-IR, A1C), binge reduction, movement, and sleep.
• Implement rhythmic eating: Aim for 4–5 feedings/day with adequate protein (e.g., 90–100 g) and high fiber intake.
• Reduce ultra-processed foods and alcohol: Prioritize whole, minimally processed foods.
• Move daily: Add short walks (e.g., 10 minutes) and incorporate resistance training and enjoyable activities like yoga or cycling.
• Consider medical therapy: Under medical supervision, discuss medications like metformin ER, tirzepatide, or semaglutide to address underlying physiology.
• Integrate chiropractic care: Address pain, mobility, and breathing mechanics to support movement and autonomic balance.
• Track biomarkers: Regularly assess progress and adjust the plan accordingly.
• Celebrate progress and treat setbacks as data: Replace perfectionism with consistency and self-compassion.

References

• Areta, J. L., Burke, L. M., Ross, M. L., Camera, D. M., West, D. W., Broad, E. M., Jeacocke, N. A., Moore, D. R., Stellingwerff, T., Phillips, S. M., Hawley, J. A., & Coffey, V. G. (2013). Timing and distribution of protein ingestion during prolonged recovery from resistance exercise alters myofibrillar protein synthesis. The Journal of Physiology, 591(9), 2319–2331. https://doi.org/10.1113/jphysiol.2012.244897
• Bauer, J., Biolo, G., Cederholm, T., Cesari, M., Cruz-Jentoft, A. J., Morley, J. E., Phillips, S., Sieber, C., Stehle, P., Teta, D., Visvanathan, R., Volpi, E., & Boirie, Y. (2013). Evidence-based recommendations for optimal dietary protein intake in older people: A position paper from the PROT-AGE Study Group. Journal of the American Medical Directors Association, 14(8), 542–559. https://doi.org/10.1016/j.jamda.2013.05.021
• Buxton, O. M., Cain, S. W., O’Connor, S. P., Porter, J. H., Duffy, J. F., Wang, W., Czeisler, C. A., & Shea, S. A. (2012). Adverse metabolic consequences in humans of prolonged sleep restriction combined with circadian disruption. Science Translational Medicine, 4(129), 129ra43. https://doi.org/10.1126/scitranslmed.3003200
• Coronado, R. A., Gay, C. W., Bialosky, J. E., Carnaby, G. D., Bishop, M. D., & George, S. Z. (2012). Changes in pain sensitivity following spinal manipulation: A systematic review and meta-analysis. Journal of Electromyography and Kinesiology, 22(5), 752–767. https://doi.org/10.1016/j.jelekin.2011.12.013
• Haavik, H., Niazi, I. K., Holt, K., & Murphy, B. (2018). The contemporary model of vertebral subluxation: A chiropractic perspective. Chiropractic & Manual Therapies, 26, 2. https://doi.org/10.1186/s12998-017-0172-3
• Hall, K. D., Ayuketah, A., Brychta, R., Cai, H., Cassimatis, T., Chen, K. Y., Chung, S. T., Costa, E., Courville, A., Darcey, V., Fletcher, L. A., Forde, C. G., Gharib, A. M., Guo, J., Howard, R., Joseph, P. V., McGehee, S., Ouwerkerk, R., Raisinger, K., … Zhou, M. (2019). Ultra-processed diets cause excess calorie intake and weight gain: An inpatient randomized controlled trial of ad libitum food intake. Cell Metabolism, 30(1), 67–77.e3. https://doi.org/10.1016/j.cmet.2019.05.008
• Hudson, J. I., Javaras, K. N., & Pope, H. G. (2014). The Binge Eating Disorder Screener-7 (BEDS-7): A brief measure for screening for binge eating disorder. Primary Care Companion for CNS Disorders, 16(1), PCC.13m01579. https://doi.org/10.4088/PCC.13m01579
• Jastreboff, A. M., Aronne, L. J., Ahmad, N. N., Wharton, S., Connery, L., Alves, B., Kiyosue, A., Zhang, S., Liu, B., Bunck, M. C., & Stefanski, A. (2022). Tirzepatide once weekly for the treatment of obesity. New England Journal of Medicine, 387(3), 205–216. https://doi.org/10.1056/NEJMoa2206038
• Jensen, M. D., Ryan, D. H., Apovian, C. M., Ard, J. D., Comuzzie, A. G., Donato, K. A., Hu, F. B., Hubbard, V. S., Jakicic, J. M., Kushner, R. F., Loria, C. M., Millen, B. E., Nonas, C. A., Pi-Sunyer, F. X., Stevens, J., Stevens, V. J., Wadden, T. A., Wolfe, B. M., & Yanovski, S. Z. (2014). 2013 AHA/ACC/TOS guideline for the management of overweight and obesity in adults: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and The Obesity Society. Circulation, 129(25 Suppl 2), S102–S138. https://doi.org/10.1161/01.cir.0000437739.71477.ee
• Jian, W., & Li, R. (2013). Metformin and polycystic ovary syndrome. Current Opinion in Obstetrics & Gynecology, 25(3), 195-200. https://doi.org/10.1097/GCO.0b013e328360219c
• Ludwig, D. S., & Ebbeling, C. B. (2018). The carbohydrate-insulin model of obesity: Beyond “calories in, calories out”. JAMA Internal Medicine, 178(8), 1098–1103. https://doi.org/10.1001/jamainternmed.2018.2933
• Neeland, I. J., Ross, R., Després, J. P., Matsuzawa, Y., Yamashita, S., Shai, I., Seidell, J., Magni, P., Santos, R. D., Arsenault, B., Cuevas, A., Frank, A. P., & Zambon, A. (2019). Visceral and ectopic fat, atherosclerosis, and cardiometabolic disease: A position statement. The Lancet. Diabetes & Endocrinology, 7(9), 715–725. https://doi.org/10.1016/S2213-8587(19)30084-1
• Rosenbaum, M., & Leibel, R. L. (2010). Adaptive thermogenesis in humans. International Journal of Obesity, 34(Suppl 1), S47–S55. https://doi.org/10.1038/ijo.2010.184
• Ryan, D. H., Lingvay, I., Deanfield, J., & Toth, P. P. (2024). Semaglutide for cardiovascular risk reduction in obesity. Reviews in Cardiovascular Medicine, 25(2), 29. https://doi.org/10.31083/j.rcm2502029
• Stenholm, S., Harris, T. B., Rantanen, T., Visser, M., Kritchevsky, S. B., & Ferrucci, L. (2008). Sarcopenic obesity: Definition, cause and consequences. Current Opinion in Clinical Nutrition and Metabolic Care, 11(6), 693–700. https://doi.org/10.1097/MCO.0b013e328312c37d
• Wild, R. A., Carmina, E., Diamanti-Kandarakis, E., Dokras, A., Escobar-Morreale, H. F., Futterweit, W., Lobo, R., Norman, R. J., Talbott, E., & Dumesic, D. A. (2010). Assessment of cardiovascular risk and prevention of cardiovascular disease in women with the polycystic ovary syndrome: A consensus statement by the Androgen Excess and Polycystic Ovary Syndrome (AE-PCOS) Society. The Journal of Clinical Endocrinology and Metabolism, 95(5), 2038–2049. https://doi.org/10.1210/jc.2009-2724

SEO Tags

integrative chiropractic, medical weight management, PCOS, insulin resistance, hyperinsulinemia, tirzepatide, semaglutide, metformin ER, binge eating disorder, GLP-1 GIP agonist, sarcopenic obesity, perimenopause weight gain, functional medicine, reproductive health, fertility, autonomic nervous system, parasympathetic, HOMA-IR, A1C, body composition, visceral adipose tissue, resistance training, Dr. Alex Jimenez DC, Dr. Maria Guadalupe Cardenas MD, Injury Medical Clinic PA, Mission Plaza Injury Medical Clinic, El Paso TX, peripheral artery disease, shared decision-making, patient-centered care, cardiovascular risk reduction, type 2 diabetes management